conference reports
9th ESOU: Debates on urothelial cancer, non-muscle invasive disease
Saturday, 21 April 2012- The second plenary session in the 9th Meeting of the EAU Section of Oncological Urology (ESOU) in Hamburg, Germany, tackled issues in bladder cancer, particularly in non-muscle invasive disease, in three...
By Joel Vega
3rd EMUC: urinary cytology unsurpassed in BCa treatment
Friday, 11 November 2011- New developments in the diagnosis and treatment of bladder cancer were discussed in the recently concluded 3rd European Multidisciplinary Meeting on Urological Cancers (EMUC) held last November 4 to...
By Evgenia Starkova
7th SEEM: urine Interleukin (Il)8 and Il5 concentration- predictive and prognostic factor in BCa patients
Wednesday, 19 October 2011- Researchers from Belgrade, Serbia conducted a study on urine Interleukin (Il)8 and Il5 concentration as a predictive and prognostic factor in patients with bladder carcinoma. Their abstract...
Filed by: J. Vega
7th SEEM: poster session on bladder cancer and uretheral surgery
Saturday, 15 October 2011- From the abstracts accepted for the presentations at the EAU 7th South Eastern European Meeting (SEEM), we reproduced below in its original version one of the submitted abstracts from Iran dealing with...
Edited by: JV
26th Annual EAU Congress: 2nd prize Best Abstract in Oncology
Wednesday, 6 April 2011- T. S. O'Brien and colleagues (London, UK) won the second prize for Best Abstract in Oncology during the 26th Annual EAU Congress held recently in Vienna, Austria. Below is the winning abstract,...
Edited by: JV
26th Annual EAU Congress: ICUD-EAU International Consultation on Bladder Cancer
Friday, 18 March 2011- The 26th Annual EAU Congress opens today with the International Consultation on Urological Diseases (ICUD) and the EAU holding a meeting on bladder cancer (BCa). The ICUD and EAU session will provide...
Edited by: JV
8th ESOU Meeting: bladder cancer session, key messages
Saturday, 22 January 2011- Issues in the detection and management of bladder cancer were discussed in the second-day plenary session of the 8th EAU Section of Urological Oncology (ESOU) Meeting (CEM) held today in London,...
By Joel Vega
Case made for chemo plus RT in invasive bladder cancer
Friday, 5 November 2010- Patients with invasive bladder cancer had a 30% reduction in the risk of recurrence with primary chemoradiation versus radiation therapy alone, according to data from a multicenter randomised...
Edited by: JV
Novel intravesical therapy for NMIBC using a genetically modified oncolytic herpes simplex virus
Monday, 1 November 2010- Researchers from Hungary, the UK and the US won the second prize for best abstract from Richard Wolf at the recently concluded 10th Central European Meeting (CEM) in Bratislava, Slovakia.
A. Horvath and...
Edited by: Joel Vega
Lectin-mediated drug delivery for intravesical treatment of bladder cancer
Tuesday, 26 October 2010- S. Polster-Wildhofen and colleagues from Vienna, Austria won the first prize for best abstract from Karl Storz at the 10th Central European Meeting (CEM) held over the weekend in Bratislava,...
Edited by: JV
